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To investigate the role of insulin receptor substrate-1
(IRS-1) and its downstream signaling in insulin-induced
thermogenic differentiation of brown adipocytes, we
have reconstituted IRS-1-deficient fetal brown adipo-
cytes (IRS-1/) with wild-type IRS-1 (IRS-1wt). The lack
of IRS-1 resulted in the inability of insulin to induce
IRS-1-associated phosphatidylinositol 3-kinase (PI 3-ki-
nase) activity and Akt phosphorylation in IRS-1/
brown adipocytes. In addition, these cells showed an
impairment in activating -Akt, -Akt, and -Akt iso-
forms upon insulin stimulation. Reconstitution of IRS-
1/ brown adipocytes with IRS-1wt restored the IRS-
1/PI 3-kinase/Akt signaling pathway. Treatment of wild-
type brown adipocytes with insulin for 24 h up-
regulated uncoupling protein-1 (UCP-1) expression and
transactivated the UCP-1 promoter; this effect was abol-
ished in the absence of IRS-1 or in the presence of an Akt
inhibitor and further recovered after IRS-1wt reconsti-
tution. Neither UCP-2 nor UCP-3 was up-regulated by
insulin in wild-type and IRS-1-deficient brown adipo-
cytes. Insulin stimulated the expression of CCAAT/en-
hancer-binding protein  (C/EBP) and its DNA binding
activity in wild-type brown adipocytes but not in IRS-
1/ cells. However, insulin stimulation of both C/EBP
expression and binding activity was restored after IRS-
1wt reconstitution of deficient cells. Retrovirus-medi-
ated expression of C/EBP and peroxisome proliferator-
activated receptor  in IRS-1/ brown adipocytes
up-regulated UCP-1 protein content and transactivated
UCP-1 promoter regardless of insulin stimulation. Both
C/EBP and peroxisome proliferator-activated receptor
 reconstituted FAS mRNA expression, but only C/EBP
restored insulin sensitivity in the absence of IRS-1.
Finally, reconstitution of IRS-1/ brown adipocytes
with the IRS-1 mutants IRS-1Phe-895, which lacks
IRS-1/growth factor receptor binding protein 2 bind-
ing but not IRS-1/p85-PI 3-kinase binding, or with IRS-
1Tyr-608/Tyr-628/Tyr-658, which only binds p85-PI 3-kinase,
induced UCP-1 expression and transactivated the UCP-1
promoter. These data provide strong evidence for an es-
sential role of IRS-1 through the PI 3-kinase/Akt signaling
pathway inducing UCP-1 gene expression by insulin.
Brown adipose tissue is a major site for non-shivering ther-
mogenesis in mammals. The unique thermogenic capacity of
brown adipose tissue results from the expression of the uncou-
pling protein-1 (UCP-1)1 in the mitochondrial inner membrane
required to address the physiological hypothermia in newborn
mammals (1). UCP-1 uncouples fatty acid oxidation from ATP
synthesis, which allows dissipation of energy from substrate
oxidation as heat (2). In addition, brown adipose tissue is a
major site for lipid metabolism, fatty acids being the main fuel
to maintain the thermogenic capacity of the tissue (for review,
see Ref. 3). It is well known that in rodents brown adipocytes
differentiate at the end of the fetal life on the basis of two
programs, an adipogenic program related to lipid synthesis and
the expression of lipogenic enzymes, resulting in a multilocular
fat droplets phenotype (4–6), and a thermogenic program re-
lated to heat production and UCP-1 expression (7). Regarding
thermogenic differentiation, the main pathway involved in the
regulation of UCP-1 gene expression is noradrenergic (8–11).
However, because the noradrenergic stimulus, induced by hy-
pothermia after birth, it is not yet fully developed in brown
adipose tissue during late fetal development (5, 9), other po-
tential candidates involved in the onset of differentiation-re-
lated gene expression have been implicated. Recently, regula-
tory elements for triiodothyronine and retinoic acid have been
identified in the UCP-1 promoter, suggesting alternative path-
ways for brown fat thermogenesis (12, 13). In addition, during
the last years our laboratory has found that fetal brown adipo-
cytes display high affinity binding sites for insulin (6). This
hormone seems to be the main signal involved in fetal brown
adipogenesis through its ability to induce the genetic expres-
sion of metabolic genes (6, 14) and may as well have a role in
thermogenesis by inducing UCP-1 expression (15).
A complex network of intracellular signaling pathways me-
diates the pleiotropic effects of insulin on metabolic processes
as well as on gene expression. Insulin initiates its biological
effects by binding to and activating its endogenous tyrosine
kinase receptors (16, 17). These receptors are believed to trans-
duce signals by phosphorylation on tyrosine residues of several
cellular substrates including IRS proteins (IRS-1, -2, -3, and -4)
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(18–21). These phosphorylated substrates then bind proteins
containing Src homology 2 domains including the p85 regula-
tory subunit of phosphatidylinositol 3-kinase (PI 3-kinase) (22),
growth factor receptor binding protein 2 (Grb-2), which links
signaling via SOS to activation of the Ras complex (23), and
protein-tyrosine phosphatase SHP2 (24), which lead to activa-
tion of various downstream signaling pathways.
Previous work from our laboratory demonstrated that fetal
brown adipocytes express high levels of both IRS-1 and IRS-2,
with the PI 3-kinase cascade being the main pathway involved
in adipogenic- and thermogenic-related gene expression (25).
More recently, we have generated immortalized fetal brown
adipocyte cell lines from IRS-1 knockout fetuses (26). These
cells are new tools in dissecting the signaling pathways emerg-
ing from IRS proteins responsible of the biological effects of
insulin in brown adipose tissue during late fetal development.
In these cells, IRS-1, but not IRS-2, is an essential requirement
for insulin-induced lipid synthesis (26). However, it remains
unclear the exact role of IRS proteins and the cytosolic signal-
ing pathways emerging downstream of IRSs that mediate in-
sulin-induced UCP-1 expression as well as the connection with
nuclear factors responsible of the transcription of the UCP-1
gene.
In the present paper we have found a failure of insulin to
induce UCP-1 expression in IRS-1-deficient fetal brown adipo-
cytes. This occurs as a result of a lack of IRS-1-associated/Akt
signaling and the loss of CCAAT/enhancer-binding protein 
(C/EBP) expression and C/EBP DNA binding activity in
response to insulin. Reconstitution with wild-type IRS-1 (IRS-
1wt) and either with the Y895F mutant (IRS-1Phe-895), which
lacks Grb-2 binding but not p85 binding, or with the IRS-1
mutant, which contains the substitution of Phe for Tyr in 18
potential tyrosine phosphorylation sites except tyrosines at
positions 608, 628, and 658 (IRS-1Tyr-608/Tyr-628/Tyr-658), results
in a recovery of insulin-mediated IRS-1/PI 3-kinase/Akt activa-
tion, transactivation of the UCP1-promoter, and UCP-1 expres-
sion. In addition, overexpression of C/EBP or PPAR
transcription factors in IRS-1-deficient brown adipocytes up-
regulates transactivation of the UCP1 promoter and UCP-1
expression bypassing insulin signaling. These results demon-
strate the essential role played by IRS-1 through the PI 3-ki-
nase/Akt-signaling pathway inducing UCP-1 gene expression
by insulin.
EXPERIMENTAL PROCEDURES
Materials—Fetal calf serum and culture media were obtained from
Invitrogen. Insulin, hygromycin, and anti-mouse IgG-agarose were
from Sigma. Protein A-agarose was from Roche Molecular Biochemi-
cals. The bleomycin analogue Zeocin was purchased from Invitrogen.
The anti-IRS-1 (06–248), anti--Akt (06–558), anti--Akt (06–606),
anti--Akt (06–607) polyclonal antibodies were purchased from Up-
state Biotechnology (Lake Placid, NY). The anti-Tyr(P) (Py20) (sc-508),
anti-C/EBP (sc-61), anti-UCP-2 (sc-6525) and anti-UCP-3 (sc-7756)
antibodies were purchased from Santa Cruz (Santa Cruz Biotechnology,
Palo Alto, CA) The anti-phospho Akt (Ser-473 No. 9271) and anti-Akt
(No. 9272) antibodies were purchased from New England Biolabs (Bev-
erly, MA). The anti-UCP-1 (AB3038) antibody was from Chemicon
(Chemicon International, CA). The anti-PPAR (S206) antibody was
from BioMol (Biomol Research Laboratories, Plymouth Meeting, PA).
[-32P]ATP (3000 Ci/mmol) and [-32P]dCTP (3000 Ci/mmol) were from
Amersham Biosciences. All other reagents used were of the purest
grade available.
Cell Culture and Retroviral Infections—Brown adipocytes were ob-
tained from interscapular brown adipose tissue of 17.5–18.5 fetuses
from 2–3 pregnant mice of normal genotype or from a pool of tissue of
fetuses obtained from 2–3 pregnant mice IRS-1/ mated with males
IRS-1/ and further submitted to collagenase dispersion as previously
described (4). Viral Bosc-23 packaging cells were transfected at 70%
confluence by calcium phosphate coprecipitation with 3 g/6-cm dish of
the puromycin resistance retroviral vector pBabe encoding SV 40 Large
T antigen (kindly provided by J. de Caprio, Dana Farber Cancer Insti-
tute, Boston, MA). Then brown adipocytes were infected at 60% conflu-
ence with Polybrene (4 g/ml)-supplemented virus for 48 h and main-
tained in culture medium for 72 h before selection with puromycin (1
g/ml) for 1 week. Several cell lines IRS-1/, IRS-1/, and IRS-1/
were cloned and expanded, and the expression of IRS-1 was assessed by
Western blot. Three clones of wild type and IRS-1/ respectively, were
cultured in Dulbecco’s modified Eagle’s medium supplemented with
10% fetal calf serum and puromycin (1 g/ml). The pBabe/hygro
C/EBP and pBabe/Zeo PPAR viral expression vectors were generous
gifts from Dr. B. Spiegelman (Dana Farber Cancer Institute, Boston,
MA). Brown adipocyte IRS-1-deficient cells (clone 4) were infected with
those vectors as described above. Selection with 200 g/ml hygromycin
or 250 g/ml Zeocin was started 48 h after infection to select stable cell
lines.
Transfections—IRS-1-deficient brown adipocytes (clone 4) were cul-
tured for 24 h in the presence of 10% fetal calf serum, and then, when
60–70% confluence was reached, cells were transfected according to the
calcium phosphate-mediated protocol with the plasmid constructs indi-
cated in each case. For pCMVhisIRS-1wt, pCMVhisIRS-1Phe-895 (derived
from IRS-1 by introducing a Phe for Tyr substitution at position 895
(27)) and pCMVhisIRS-1Tyr-608/Tyr-628/Tyr-658 (derived from IRS-1-F18 by
adding back Tyr at positions 608, 628, and 658 (28)) constructs, 10 g of
DNA were added to each dish. After 4–6 h of incubation, cells were
shocked with 3 ml of 15% glycerol for 2 min, washed, and then fed with
Dulbecco’s modified Eagle’s medium, 10% fetal calf serum. 24 h after
transfection, histidinol (10 mM) was added to select stable
transfectants.
Immunoprecipitations—Quiescent cells (20 h serum-starved) were
treated without or with several doses of insulin as indicated and lysed
at 4 °C in 1 ml of a solution containing 10 mM Tris/HCl, 5 mM EDTA, 50
mM NaCl, 30 mM sodium pyrophosphate, 50 mM NaF, 100 M Na3VO4,
1% Triton X-100, and 1 mM phenylmethylsulfonyl fluoride, pH 7.6 (lysis
buffer). Lysates were clarified by centrifugation at 15,000  g for 10
min. After protein content determination, equal amounts of protein
(500–600 g) were immunoprecipitated at 4 °C with the corresponding
antibodies. The immune complexes were collected on protein A-agarose
or anti-mouse IgG-agarose beads. Immunoprecipitates were washed
with lysis buffer and extracted for 5 min at 95 °C in 2 SDS-PAGE
sample buffer (200 mM Tris/HCl, 6% SDS, 2 mM EDTA, 4% 2-mercap-
toethanol, 10% glycerol, pH 6.8) and analyzed by SDS-PAGE.
Western Blotting—After SDS-PAGE, proteins were transferred to
Immobilon membranes and blocked using 5% nonfat dried milk or 3%
bovine serum albumin in 10 mM Tris-HCl, 150 mM NaCl, pH 7.5, and
incubated overnight with several antibodies as indicated in 0.05%
Tween 20, 10 mM Tris-HCl, 150 mM NaCl, pH 7.5. Immunoreactive
bands were visualized using the ECL Western-blotting protocol (Amer-
sham Biosciences).
PI 3-Kinase Activity—PI 3-kinase activity was measured in the anti-
IRS-1 or anti-Tyr(P) immunoprecipitates by in vitro phosphorylation of
phosphatidylinositol as previously described (25).
Akt Activity—For Akt activity, cells were lysed in Buffer A containing
50 mM Tris-HCl, pH 7.5, 0.1% Triton X-100, 1 mM EDTA, 1 mM EGTA,
50 mM sodium fluoride, 10 mM sodium -glycerol phosphate, 5 mM
sodium pyrophosphate, 1 mM Na3VO4, and 0.1% -mercaptoethanol and
subjected to immunoprecipitation with the anti--Akt, anti--Akt, or
anti--Akt polyclonal antibodies as described above. The immunopre-
cipitates were washed 3 times with buffer A containing 0.5 M NaCl, 2
times with Buffer B containing 50 mM Tris-HCl, pH 7.5, 0.03% Brij-35,
0.1 mM EGTA, 0.1% -mercaptoethanol, and once with Buffer ADB
containing 20 mM MOPS, pH 7.2, 25 mM sodium -glycerol phosphate,
pH 7, 0.1 mM Na3VO4, 1 mM dithiothreitol. The kinase reaction was
started by adding to each sample 10 l of Buffer ADB, protein kinase A
inhibitor to a final concentration of 17 M, 10 l of 30 M Akt/synthetic
peptide of glycogen synthase kinase-3 (SGK) substrate peptide (Upstate
Biotechnology, catalog No. 12–340), and 10 Ci of [-32P]ATP (3000
Ci/mmol). After 10 min of incubation at 30 °C, the reaction was termi-
nated by blotting 25 l of the supernatant fraction on a P81 paper
square (Whatman). Filters were washed 3 times with 0.75% phosphoric
acid and once with acetone, and the radioactivity remaining on the
filters was measured.
Isolation of Mitochondrial Protein—At the end of the culture time,
cells were scraped off in isotonic isolation buffer (1 mM EDTA, 10 mM
HEPES, 250 mM sucrose, pH 7.6), collected by centrifugation at 2500 
g for 5 min at 4 °C, and resuspended in hypotonic isolation buffer (1 mM
EDTA, 10 mM HEPES, 50 mM sucrose, pH 7.6). Then cells were incu-
bated at 37 °C for 5 min and homogenized under a Teflon pestle (Over-
head Stirrer; Wheaton Instruments, Milville, NJ). Hypertonic isolation
buffer (1 mM EDTA, 10 mM HEPES, 450 mM sucrose, pH 7.6) was added
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to balance the buffer tonicity. Samples were centrifuged at 10,000  g
for 10 min, the pellets, containing the mitochondrial fraction, were
resuspended in isotonic isolation buffer, and mitochondrial protein con-
tent was determined.
Protein Determination—Protein determination was performed by the
Bradford dye method (29) using the Bio-Rad reagent and bovine serum
albumin as the standard.
RNA Extraction and Northern Blot Analysis—At the end of the
culture time, cells were washed twice in ice-cold phosphate-buffered
saline, and RNA was isolated as described (30). Total cellular RNA (10
g) was submitted to Northern blot analysis, i.e. electrophoresed on
0.9% agarose gels containing 0.66 M formaldehyde, transferred to
GeneScreen membranes (PerkinElmer Life Sciences), and cross-linked
to the membranes by ultraviolet light. Hybridization was performed in
0.25 mM Na2HPO4, pH 7.2, 0.25 M NaCl, 100 g/ml denatured salmon
sperm DNA, 7% SDS, and 50% deionized formamide containing dena-
tured 32P-labeled cDNA (106 cpm/ml) for 24 h at 42 °C. cDNA labeling
was carried out with [-32P]dCTP by using a multiprimer DNA-labeling
system. Blots were hybridized with probes for fatty acid synthase (FAS)
(31) and with 18 S ribosomal probe to normalize. Membranes were
subjected to autoradiography, and the relative densities of the hybrid-
ization signals were determined by densitometric scanning of the
autoradiograms.
Extraction of Nuclear Proteins and Gel Mobility Shift Assays—Cells
were resuspended at 4 °C in 10 mM HEPES-KOH, pH 7.9, 1.5 mM
MgCl2, 10 mM KCl, 0.5 mM dithiothreitol, 0,2 mM phenylmethylsulfonyl
fluoride, 0.75 g/ml leupeptin, 0.75 g/ml aprotinin (Buffer A), allowed
to swell on ice for 10 min, and then vortexed for 10 s. Samples were
centrifuged, and the pellet was resuspended in cold buffer C (20 mM
HEPES-KOH, pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2
mM EDTA, 0.5 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluo-
ride, 0.75 g/ml leupeptin, 0.75 g/ml aprotinin) and incubated on ice
for 20 min for high salt extraction. Cellular debris was removed by
centrifugation for 2 min at 4 °C, and the supernatant fraction was
stored at70 °C. The gel mobility shift assay was performed essentially
as previously described (32). The double-stranded oligonucleotide used
as C/EBP probe, corresponding to the nuclear factor-interleukin-6
(NF-IL6) site of the COX2 promoter (5-GGGTATTATGCAATTG-
GAAG-3), was synthesized in a Pharmacia oligonucleotide synthesizer.
Labeling was performed by using Klenow polymerase and [-32P]dCTP.
The binding reaction mixture contained 0.5 ng of doubled-stranded
oligonucleotide probe, 2 g of poly(dI)poly(dC), and 10 g of protein in
Buffer C supplemented with 35 mM MgCl2. In some lanes a 100-fold
excess of unlabeled oligonucleotide was used to compete away specific
complexes. After 20 min of incubation at 4 °C, the mixture was electro-
phoresed through a 6% polyacrylamide gel in 0.5 Tris borate-EDTA
running buffer for 2 h. Gels were then dried and subjected to autora-
diography as well as quantified directly with a radioimaging device.
Supershift assays were carried out after incubation of the nuclear
extracts with 0.5 g of either C/EBP or nonspecific (non-immune
rabbit serum) antibodies for 1 h at 4 °C.
CAT Assays—Cells growing in the presence of 10% fetal serum were
transiently transfected according to the calcium phosphate-mediated
protocol as described above. The plasmid constructs used were 4551
UCP-1-CAT (where the CAT reporter gene is under the control of a
4551-bp full-length 5-flanking region of the UCP-1 promoter) (33),
3628/2283/linked to 141 CAT corresponding with a deletion mu-
tant of the UCP-1 proximal promoter that does not contain C/EBP
binding sites (34) and pCMV -galactosidase (gal) (a viral promoter
driving expression of the reporter gene -gal). Ten micrograms of DNA-
CAT together with 2 g of DNA--gal (to monitor transfection effi-
ciency) were added to each 10-cm dish. After 4 h of incubation, cells
were fed with serum-free medium for 15 h and stimulated with various
doses of insulin for a further 24 h. Then cells were harvested, and
lysates were prepared for CAT and -gal activity assays. CAT activity
was determined by incubating 70 l of cell extracts with 0.25 Ci of
[14C]chloramphenicol and 0.5 mM acetyl coenzyme A in 0.25 mM Tris,
pH 7.8, at 37 °C for 15 h, and then samples were submitted to TLC. The
amount of substrate acetylated was directly quantified with a radioim-
aging device (Fujifilm BAS-1000, Japan). CAT enzyme activity was
expressed in arbitrary units normalized to the internal control -gal
(assayed according to the Stratagene protocol).
FIG. 1. Reconstitution of IRS-1 expression and PI 3-kinase activity in IRS-1-deficient brown adipocytes. A, IRS-1-deficient brown
adipocytes (clone 4) were cultured until 60–70% confluence was reached. Then cells were transfected with the pCMVhisIRS-1wt construct according
to the calcium phosphate-mediated protocol. 24 h after transfection, histidinol (10 mM) was added to select stable transfectants. Several
histidinol-resistant cell lines were obtained, and the expression of IRS-1wt was assessed by Western blot with the anti-IRS-1 antibody. B, quiescent
cells (IRS-1/, pCMVhisIRS-1wt and IRS-1/) were stimulated with 10–100 nM insulin for 5 min. Cell lysates were immunoprecipitated (IP) with
anti-IRS-1 or anti-Tyr(P) (pY) antibodies and immediately used for an in vitro PI 3-kinase assay. A representative experiment is shown. The
autoradiograms corresponding to three independent experiments were analyzed by scanning densitometry. Results are expressed as arbitrary
units of PI 3-kinase activity and are the means  S.E. PIP, inositol trisphosphate.
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Cellular Oxygen Consumption—Confluent cells (IRS-1/ and IRS-
1/) were cultured for 20 h in serum-free medium and further stimu-
lated with insulin (100 nM) for 24 h. Then cells were trypsinized and
resuspended in 1 ml of serum-free Dulbecco’s modified Eagle’s medium
supplemented with 1% (w/v) bovine serum albumin. Basal oxygen con-
sumption rates were measured in a HANSA-TECH oxygen electrode in
the presence of 30 M palmitate as described (35). Values were normal-
ized by cell number. The uncoupler carbonyl cyanide p-trifluorome-
thoxyphenylhydrazone at 10 M totally collapsed the proton gradient
and allowed the determination of the fully uncoupled respiration rate.
RESULTS
Reconstitution of IRS-1 in IRS-1-deficient Fetal Brown Adi-
pocytes Restores IRS-1- and Phosphotyrosine-associated PI
3-Kinase Activity—We have previously shown that immortal-
ized fetal brown adipocytes derived from fetuses of IRS-1-defi-
cient mice completely lack response to 10 nM insulin in activat-
ing IRS-1-associated PI 3-kinase activity, and we also showed a
30% reduction in total PI 3-kinase activity in anti-phosphoty-
rosine (pY) immunoprecipitates (26). To investigate whether
this response could be recovered by reintroducing wild-type
IRS-1 (IRS-1wt), we reconstituted IRS-1 expression in IRS-1-
deficient brown adipocytes. These cells were transfected with
the pCMVhisIRS-1wt cDNA construct, and stable cell lines
were selected in 10 mM histidinol-containing medium. Fig. 1A
shows that IRS-1wt expression in the reconstituted cell lines
represents about 60% that seen in wild-type cells. IRS-1-asso-
ciated PI 3-kinase activity was recovered in reconstituted
brown adipocytes in parallel to the level of IRS-1wt protein
expressed (Fig. 1B). Likewise, insulin-induced antiphosphoty-
rosine-associated PI 3-kinase activity, which was reduced by
30% in IRS-1/cells, was totally recovered after IRS-1wt
reconstitution.
Insulin-induced Phosphorylation and Activation of Akt Is
Recovered after IRS-1wt Reconstitution in IRS-1/ Fetal
Brown Adipocytes—Because the serine/threonine kinase Akt is
one of the major downstream targets of PI 3-kinase, we ex-
plored the phosphorylation of -Akt and -Akt isoforms as well
as total Akt phosphorylation by direct Western blot analysis in
wild-type , IRS-1/ , and IRS-1wt-reconstituted brown adipo-
cytes. In fetal brown adipocytes, the lack of IRS-1 resulted in a
loss of AktSer-473 phosphorylation; only a remnant AktSer-473
phosphorylation was detected at 100 nM insulin concentration
(Fig. 2A). Both -Akt and -Akt isoforms were phosphorylated
upon insulin (10–100 nM) stimulation of wild-type brown adi-
pocytes, as shown by the electrophoretic mobility shifts in the
presence of the hormone, these effect being precluded in IRS-
1/ cells. The reintroduction of IRS-1wt in IRS-1/ brown
adipocytes resulted in a recovery of AktSer-473 phosphorylation
as well as -Akt, -Akt phosphorylation as shown by immuno-
detection with the anti-phospho specific AktSer-473 antibody, or
by the mobility shifts observed in insulin-stimulated cells with
the anti--Akt, -Akt, and total Akt antibodies. To confirm the
results obtained from the phospho-Akt analysis, Akt kinase
assays were performed in insulin-stimulated IRS-1/, IRS-
1/, and IRS-1wt-reconstituted fetal brown adipocytes after
immunoprecipitation with the specific antibodies for each Akt
isoform. As shown in Fig. 2B, -Akt kinase activity was en-
hanced by 2- or 3-fold at 10 nM or 100 nM insulin concentra-
tions, respectively, in wild-type brown adipocytes. Activation of
-Akt by insulin was totally blunted in IRS-1/ cells, whereas
reconstituted IRS-1wt cells recovered the level of insulin-in-
duced -Akt activity observed in wild-type cells. A modest
increase in -Akt activity was observed in wild-type cells upon
FIG. 2. Reconstitution of insulin-induced Akt phosphorylation and Akt activation by IRS-1wt expression in IRS-1-deficient brown
adipocytes. A, quiescent cells were stimulated with various doses of insulin for 5 min and then lysed. Equals amount of protein (50 g) were
analyzed by Western blot with the anti-phospho-Akt (PAkt, Ser-473), anti-total Akt, anti--Akt, and anti--Akt antibodies. A representative
experiment of five is shown. B, quiescent cells were stimulated with various doses of insulin for 5 min and then lysed. Equals amount of protein
(600–800 g) were immunoprecipitated with anti--Akt, anti--Akt, and anti--Akt antibodies and immediately used for an in vitro kinase assay
as described under “Experimental Procedures.” Quantitative data are expressed in cpm and are the means  S.E. from 3–4 independent
experiments.
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100 nM insulin stimulation; no effect on -Akt activity was
detected in IRS-1/ cells. Reconstituted IRS-1wt cells recov-
ered the level of insulin-induced -Akt activity in parallel to the
level of IRS-1wt protein expressed (see Fig. 1A). Insulin in-
creased -Akt activity in a dose-dependent manner in wild-type
brown adipocytes, with its maximal effect (3–3.5-fold) elicited
at 100 nM insulin concentration. Likewise, insulin failed to
activate -Akt isoform in IRS-1/ brown adipocytes, whereas
IRS-1wt-reconstituted cells recovered insulin response in acti-
vating -Akt in parallel to the level of IRS-1wt protein
expressed.
Insulin-dependent UCP-1 Expression and Transactivation of
the Full-length UCP-1 Promoter Is Impaired in IRS-1-deficient
Brown Adipocytes—We have previously shown that either in-
sulin or IGF-I are novel thermogenic factors in brown adipocyte
primary cultures involved in UCP-1 expression during late
fetal development; this effect was precluded by PI-3 kinase
inhibitors (15, 25). Accordingly, our next step was to assess if
IRS-1 could be the main docking protein connecting insulin-
induced PI 3-kinase/Akt signaling pathway with UCP-1 expres-
sion. UCP-1 protein content was analyzed by direct Western
blot analysis in mitochondrial protein extracts of wild-type,
IRS-1/, and reconstituted IRS-1wt brown adipocytes treated
for 24 h with various doses of insulin. As shown in Fig. 3A,
insulin increased UCP-1 expression in wild-type-immortalized
fetal brown adipocytes in a dose-dependent manner as com-
pared with untreated cells. The lack of IRS-1 totally precluded
insulin effect on UCP-1 expression. However, we did not find
changes in the basal cellular oxygen consumption either in
wild-type or IRS-1-deficient cells in response to insulin using
palmitate (30 M) as a substrate (results not shown), suggest-
ing that the cellular respiratory status is not dependent on the
level of UCP-1 content found under our experimental condi-
tions. UCP-1 expression in response to insulin was recovered
when we added back IRS-1wt to IRS-1/ brown adipocytes in
parallel to the level of protein expressed. In addition we tested
the effect of ML-9 compound (an inhibitor of Akt activity) (36)
on insulin-induced UCP-1 expression in wild-type brown adi-
pocytes. Inhibition of Akt resulted in a loss of insulin response
in inducing UCP-1 expression in wild-type brown adipocytes as
well as in IRS-1-reconstituted null cells (results not shown).
However, neither UCP-2 nor UCP-3 expression was up-regu-
lated by insulin in wild-type and IRS-1-deficient brown adipo-
cytes (Fig. 3B). Another approach was to study the effect of
insulin in transactivating the UCP-1 promoter in the three cell
types. Cells were transiently transfected with the 4551-bp full-
length UCP-1 promoter driving the expression of the CAT
reporter gene (33). Upon transfection, cells were cultured for
24 h in a serum-free medium either in the absence or presence
of 100 nM insulin, and then CAT activity was determined. As
shown in Fig. 3C, the 4551-CAT fusion gene was weakly tran-
scribed in unstimulated wild-type brown adipocytes, whereas
FIG. 3. Insulin-dependent UCP-1 and FAS expression and transactivation of UCP-1 promoter is impaired in IRS-1-deficient brown
adipocytes. A, wild-type (IRS-1/), IRS-1-deficient (IRS-1/), and IRS-1-reconstituted (pCMVhisIRS-1wt) brown adipocytes (20 h serum-
starved) were cultured for an additional 24 h in serum-free medium either in the absence or presence of insulin (10–100 nM). Serum-starved
wild-type brown adipocytes were cultured for an additional 24 h in serum-free medium either in the absence or presence of insulin (10–100 nM)
and ML-9 (50 M). Then cells were harvested, and mitochondrial protein extracts were analyzed by Western blot with anti-UCP-1 or anti-
cytochrome c antibodies. B, serum-starved wild-type and IRS-1/ brown adipocytes were cultured for 24 h in serum-free medium either in the
absence or presence of insulin (10–100 nM). Mitochondrial protein extracts were analyzed by Western blot with anti-UCP-2, anti-UCP-3, or
anti-cytochrome c antibodies. Representative experiments are shown. C, wild-type, IRS-1/, and pCMVhisIRS-1wt brown adipocytes were
transiently transfected with 10 g of 4551 full-length promoter UCP-1-CAT fusion gene. Upon transfection, cells were cultured for 24 h in
serum-free medium either in the absence or in the presence of 100 nM insulin or 0.5 mM dibutyryl cAMP (dbcAMP) and assayed for CAT activity.
The relative CAT activity normalized to -gal activity is represented in the histogram. Results are the means  S.E. from three independent
experiments. D, quiescent cells were cultured for 24 h in serum-free medium either in the absence or presence of insulin (10–100 nM). At the end
of the culture time, total RNA (10 g) was submitted to Northern blot analysis and hybridized with labeled FAS and 18 S rRNA cDNAs.
Representative autoradiograms are shown.
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insulin treatment resulted in 2.5-fold increase in CAT activity.
IRS-1/ brown adipocytes lacked insulin stimulation of UCP-1
CAT activity; meanwhile, re-expression of IRS-1wt in these
cells resulted in a recovery of insulin-induced UCP-1 CAT
activity in accordance with the level of reconstitution. As a
positive control, 0.5 mM dibutyryl cAMP stimulation caused a
4-fold increase in UCP-1 CAT activity.
To substantiate the role of IRS-1 in insulin-induced brown
adipocyte differentiation we also tested whether the lack of
IRS-1 could affect the expression of FAS, an enzyme involved in
brown adipocyte lipid synthesis. As shown in Fig. 3D, FAS
mRNA expression was induced in insulin-treated wild-type
brown adipocytes; this effect was precluded in IRS-1/ cells
and was further recovered in IRS-1wt-reconstituted cells.
Insulin-induced C/EBP Expression and Its DNA Binding
Activity in an IRS-1-dependent Manner—It has been reported
that the 5-flanking region of the UCP-1 gene contains C/EBPs-
regulated sites (37). In fact, previous data from our laboratory
indicated that the three canonical C/EBP isoforms (, , and )
are expressed in brown adipose tissue during late fetal devel-
opment, with C/EBP positively regulated by insulin (5, 14).
Based on that our next goal was to investigate whether IRS-1-
mediated insulin signaling could be involved in the nuclear
expression of C/EBP and its DNA binding activity, which has
also been described in the promoters of a number of adipogenic
genes (38, 39). First, we tested the expression of C/EBP in
response to insulin in wild-type, IRS-1/, and reconstituted
IRS-1wt brown adipocyte cell lines. As shown in Fig. 4A, insulin
(10–100 nM) treatment for 24 h induced p42C/EBP expression
in wild-type cells, but not in IRS-1-deficient cells; insulin-in-
duced p42C/EBP expression was recovered in IRS-1wt-recon-
stituted cells in parallel to the level of protein reconstitution. In
all the experiments similar loading of protein extracts was
assessed by Ponceau red staining of the membranes. Next,
electrophoretic mobility shift assays were conducted to deter-
mine whether the insulin effect on C/EBP protein levels would
be reflected in its binding to the cognate DNA recognition sites.
We isolated nuclear extracts from wild-type, IRS-1/, and
reconstituted IRS-1wt brown adipocyte cell lines, which had
been stimulated with insulin as described above. As shown in
Fig. 4B, left panel, the gel shift band patterns revealed the
binding of nuclear proteins from wild-type brown adipocytes to
an oligonucleotide probe corresponding to the C/EBP consensus
site in an insulin-dependent manner, in parallel with C/EBP
protein expression. In supershift assays, incubation with
C/EBP antibody, but not with a nonspecific antibody, totally
eliminated the specific C/EBP binding (Fig. 4B, middle panel).
However, the insulin effect on the C/EBP binding activity was
blunted in cells lacking IRS-1. This effect was partially recov-
ered after reconstitution with IRS-1wt (Fig. 4B, left panel).
Finally, the requirement of C/EBP binding sites within the
UCP-1 promoter for insulin-induced transactivation was tested
FIG. 4. Insulin-induced C/EBP expression and its DNA binding activity in an IRS-1-dependent manner. A, serum-starved cells were
cultured for a further 24 h in serum-free medium either in the absence or presence of insulin (10–100 nM). Nuclear protein extracts were analyzed
by Western blot with the anti-C/EBP antibody. A representative experiment is shown. The autoradiograms corresponding to 4–5 independent
experiments were analyzed by scanning densitometry. Results are expressed as arbitrary units of C/EBP protein content and are the means 
S.E. B, left panel, serum-starved cells were stimulated with insulin (10–100 nM) for 24 h. Ten g of nuclear extracts were incubated for 20 min with
0.5 ng of 32P-labeled doubled-stranded oligonucleotide used as C/EBP (see “Experimental Procedures”). A competition assay using a 100-fold
excess of unlabeled oligonucleotide was performed to obtain nonspecific binding activity (lane ). Then the mixture was electrophoresed through
a 6% (w/v) polyacrylamide gel. An autoradiogram of a representative mobility shift assay of three is shown. Middle panel, wild-type cells (IRS-1/)
were stimulated with insulin (Ins) for 24 h, and nuclear extracts (10 g) were incubated with 0.5 g of anti-C/EPP or nonspecific antibodies for
1 h at 4 °C and then for a further 20 min with 0.5 ng of 32P-labeled probe. An autoradiogram of a representative supershift assay is shown. Right
panel, wild-type brown adipocytes were transiently transfected with 10 g of 4551 full-length promoter UCP-1-CAT fusion gene or with 4551
UCP-1(2283/141) CAT construct. Upon transfection, cells were cultured for 24 h in serum-free medium either in the absence or in the presence
of 100 nM insulin and assayed for CAT activity. The relative CAT activity normalized to -gal activity is represented in the histogram. Results are
means  S.E. from three independent experiments. Ab, antibody. C/EBPdel, C/EBP deletion.
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by using a mutant in which the proximal promoter containing
the C/EBP binding sites had been deleted (3628/2283 linked
to 141CAT (34)). As shown in Fig. 4B (right panel), the
transactivation of the UCP-1 promoter induced by insulin in
wild-type brown adipocytes was totally abolished in the ab-
sence of C/EBP binding sites.
Retroviral Expression of C/EBP or PPAR Bypasses Insulin
Signaling in Inducing UCP-1—The fact that C/EBP and
PPAR transcription factors have been implicated in adipocyte
differentiation by a number of laboratories prompted us to
investigate whether overexpression of these transcription fac-
tors is able to bypass insulin signaling in inducing UCP-1
expression in the absence of IRS-1. For this goal, we performed
retrovirus-mediated C/EBP or PPAR gene transfer into IRS-
1/ brown adipocytes (Fig. 5A). After retroviral infection,
C/EBP was overexpressed in the IRS-1/ cell line about
10-fold, reaching higher levels than those observed in primary
brown adipocytes. On the other hand, PPAR was overex-
pressed about 4-fold, reaching similar levels than those in
primary cells. Both C/EBP- and PPAR- overexpressing IRS-
1/ cells up-regulated UCP-1 expression as compared with
either wild-type or IRS-1/ brown adipocytes. To further an-
alyze the insulin effect on UCP-1 protein levels in C/EBP- and
PPAR-IRS-1/ cells, we performed anti-UCP-1 Western blot
analysis after 24 h of insulin stimulation (Fig. 5B). In both
serum-deprived C/EBP- or PPAR-IRS-1/ cells UCP-1 ex-
pression was up-regulated, and insulin treatment did not fur-
ther increase UCP-1 protein levels. In addition, transient
transfection of C/EBP- or PPAR-IRS-1/ cells with the full-
length UCP-1 promoter fused to the CAT reporter gene re-
vealed that both transcription factors induced the transactiva-
tion of the UCP-1 promoter in the absence of insulin; no further
increase was observed by 24 h of insulin treatment (Fig. 5C). As
an adipogenic marker, we analyzed FAS mRNA levels in insu-
lin-stimulated C/EBP- and PPAR-IRS-1/ cells. The North-
ern blot depicted in Fig. 5D revealed that FAS mRNA was also
up-regulated; this effect was truly significant in C/EBPIRS-
1/cells. However, insulin treatment induced a slight further
increase in FAS mRNA in C/EBPIRS-1/cells but not in
PPARIRS-1/cells.
Reconstitution of IRS-1-deficient Brown Adipocytes with
IRS-1Phe-895 Mutant Restores IRS-1/Akt Signaling and Insulin
Effect on UCP-1 Expression—We have recently shown that
IRS-1Phe-895 mutant, which does not bind Grb-2, overexpressed
in IRS-1-deficient brown adipocytes failed to activate the Ras/
mitogen-activated protein kinase signaling pathway and cell
proliferation in response to insulin (40). To test whether recon-
stitution of IRS-1/ brown adipocytes with IRS-1Phe-895 mu-
tant restores IRS-1/PI 3-kinase/Akt signaling pathway, we
transfected a pCMVhisIRS-1Phe-895 mutant in which the tyro-
sine in position 895 (which has been shown to be responsible for
Grb-2 association) was replaced by phenylalanine (27), and
histidinol-resistant cell lines were selected for further experi-
ments. Fig. 6A shows that IRS-1wt and IRS-1Phe-895 expression
in the reconstituted cell lines represents about 50–60% that
seen in wild-type cells. In addition, we attempted to determine
FIG. 5. Differential recovery of UCP-1 and FAS expression by overexpression of C/EBP and PPAR transcription factors in
IRS-1-deficient brown adipocytes. A, IRS-1/ fetal brown adipocyte cell lines overexpressing C/EBP or PPAR were generated as described
under “Experimental Procedures.” Nuclear extracts were prepared from growing cells (10% fetal serum) and analyzed by Western blot with the
anti-C/EBP and anti-PPAR antibodies. To analyze UCP-1 expression, mitochondrial protein extracts were isolated and analyzed by Western blot
with the corresponding anti-UCP-1 antibody. Results are representative of at least two independent experiments. B, IRS-1/ brown adipocytes
and IRS-1/ cells overexpressing C/EBP or PPAR were serum-starved for 20 h and further cultured for 24 h in the absence or presence of insulin
(10–100 nM). Mitochondrial protein extracts were analyzed by Western blot with anti-UCP-1 or anti-cytochrome c antibodies. C, cells were
transiently transfected with 10 g of 4551 full promoter UCP-1-CAT fusion gene. Upon transfection, cells were cultured for 24 h in serum-free
medium either in the absence or in the presence of 100 nM insulin and assayed for CAT activity. The relative CAT activity normalized to -gal
activity is represented in the histograms. Results are the means  S.E. from three independent experiments. D, quiescent cells were cultured for
24 h in serum-free medium either in the absence or presence of insulin (10–100 nM). At the end of the culture time, total RNA (10 g) was submitted
to Northern blot analysis and hybridized with labeled FAS and 18 S rRNA cDNAs. Representative autoradiograms are shown.
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if exogenously expressed IRS-1wt and IRS-1Phe-895 were func-
tional in activating PI 3-kinase/Akt signaling in response to
insulin stimulation. IRS-1Phe-895-reconstituted cells induced
IRS-1-associated PI-3 kinase activity and total Akt phospho-
rylation; no differences were found with IRS-1wt cells (Fig. 6B).
Next we studied the effect of IRS-1Phe-895 reconstitution on
insulin-induced thermogenic differentiation monitored by the
expression of UCP-1. As shown in Fig. 6C, IRS-1Phe-895 brown
adipocytes reconstituted UCP-1 expression as IRS-1wt cells.
Furthermore, insulin-induced expression of C/EBP was also
recovered by re-expression of IRS-1Phe-895. Finally, IRS-1Phe-895
mutant also restored the transactivation of the UCP-1 pro-
moter in response to insulin, which had been abolished in
IRS-1-deficient cells (Fig. 6D). As a control of insulin-induced
adipogenic differentiation, we determined FAS mRNA in insu-
lin-stimulated IRS-1/ brown adipocytes reconstituted with
IRS-1Phe-895. As shown in the representative Northern blot
(Fig. 6E), FAS mRNA levels in response to insulin in
IRS-1Phe-895 brown adipocytes were similar of those observed in
IRS-1wt cells.
Binding of Tyrosines 608, 628, and 658 to p85 Is Sufficient to
Restore PI-3 Kinase/Akt Signaling and Insulin-induced UCP-1
and FAS Expression in Brown Adipocytes—To substantiate the
contribution of PI 3-kinase/Akt signaling pathway to insulin-
induced FAS and UCP-1 expression in fetal brown adipocytes,
we transfected the pCMVhisIRS-1Tyr-608/Tyr-628/Tyr-658 mutant,
which fully restores PI 3-kinase activity in response to insulin at
a level comparable with that seen with wild-type IRS-1 (28). Fig.
7A shows that IRS-1wt and IRS-1Tyr-608/Tyr-628/Tyr-658 expression
in the reconstituted cell lines represents about 50–60% that seen
in wild-type cells. Indeed, IRS-1Tyr-608/Tyr-628/Tyr-658-reconstituted
IRS-1-deficient brown adipocytes induced IRS-1-associated
PI-3 kinase activity and Akt phosphorylation to the same
extent as IRS-1wt cells upon insulin stimulation (Fig. 7B).
Furthermore, we studied the effect of IRS-1Tyr-608/Tyr-628/Tyr-658
reconstitution in insulin-induced brown adipocyte thermogenic
and adipogenic differentiation, monitored by the expression of
UCP-1 (Fig. 7C) and FAS (Fig. 7D), respectively. The mutant
IRS-1Tyr-608/Tyr-628/Tyr-658 brown adipocytes reconstituted UCP-1
protein expression as well as FAS mRNA expression at a level
comparable with that seen with IRS-1wt cells.
DISCUSSION
A report from our laboratory demonstrates that differen-
tiation of brown adipose tissue occurs during late fetal devel-
opment and could be monitored by the expression of a set of
adipogenic enzymes (FAS, glycerol 3-phosphate dehydrogen-
ase (G3PD), malic enzyme, and acetyl-CoA carboxylase
(ACC), etc.) as well as the thermogenic marker UCP-1 (5).
Despite the fact that the noradrenergic stimulus is not yet
fully developed at this stage of development (9), insulin and
IGF-I have been identified as signals able to induce the
FIG. 6. IRS-1Phe-895 mutant reconstitutes PI-3 kinase/Akt signaling and insulin-induced UCP-1 and FAS expression. A, IRS-1-
deficient brown adipocytes (clone 4) were transfected with the pCMVhisIRS-1wt (IRS-1wt) and pCMVhisIRS-1Phe-895 (IRS-1Phe-895) cDNA constructs.
24 h after transfection, histidinol (10 mM) was added to select stable transfectants, and the expression of IRS-1wt and the mutant IRS-1Phe-895 was
assessed by Western blot with the anti-IRS-1 antibody. B, quiescent cells (IRS-1/, IRS-1wt, and IRS-1Phe-895 stable transfectants) were stimulated
with various doses of insulin for 5 min, and total protein (inositol trisphosphate (PIP)) was either immunoprecipitated (IP) with the anti-IRS-1
antibody followed by an in vitro PI 3-kinase assay as described above or submitted to Western blot analysis with anti-phospho-Akt (PAkt)and
anti-Akt antibodies. A representative experiment of three is shown. C, quiescent cells were cultured for 24 h in the absence or presence of insulin
(10–100 nM). Mitochondrial extracts were analyzed by Western blot with anti-UCP-1 and anti-cytochrome c, and nuclear protein extracts were
analyzed by Western blot with anti-C/EBP. Representative autoradiograms are shown. D, cells were transiently transfected with 10 g of 4551
full promoter UCP-1-CAT fusion gene. Upon transfection, cells were cultured for 24 h in serum-free medium either in the absence or in the presence
of 100 nM insulin. At the end of the culture period, cells were collected and assayed for CAT activity. The relative CAT activity normalized to -gal
activity is represented in the histograms. Results are the means  S.E. from three independent experiments. E, quiescent cells were cultured for
24 h in serum-free medium either in the absence or presence of insulin (10–100 nM). At the end of the culture time, total RNA (10 g) was submitted
to Northern blot analysis and hybridized with labeled FAS and 18 S rRNA cDNAs.
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expression of UCP-1 concurrent with the adipogenic genes (4,
6), based on the fact that brown adipocytes display high
number of receptors and affinity for both molecules (6).
The first part of this paper (Figs. 1- 3) is focused on the
upstream elements in the insulin-signaling cascade involved in
insulin-induced UCP-1 expression. For this goal, we have used
immortalized brown adipocytes derived from the fetuses of
IRS-1-deficient mice as well as from the wild type. These cells
maintain the adipogenic and thermogenic phenotype of brown
adipocytes under growing conditions regardless of the process
of immortalization. However, IRS-1-deficient cells showed
lower cytosolic lipid content than wild-type cells when cultured
under serum-free conditions (26). IRS-1 has recently been de-
scribed as an essential signaling molecule acting through the
PI 3-kinase pathway in inducing the adipocyte differentiation
in in vitro protocols developed in mouse fibroblasts (41) and
brown fat preadipocytes (42). Accordingly, we explored this
pathway in fetal brown adipocytes as a possible molecular
mechanism responsible of insulin-induced UCP-1 expression.
Our previous work demonstrated a failure of insulin in activat-
ing Akt Ser473 phosphorylation in IRS-1/ brown adipocytes
despite the fact of IRS-2 overexpression and enhanced IRS-2-
associated PI 3-kinase activity (26). Here we show that in these
cells insulin-induced IRS-1-mediated PI 3-kinase activation
can be recovered by reconstitution of IRS-1wt expression by
retroviral gene transfer. Consequently, total Akt Ser473 phos-
phorylation as well as phosphorylation of -Akt and -Akt
isoforms were recovered. We further confirmed these results by
measuring Akt enzymatic activity. Of the three isoforms of Akt
assessed in this study, - and -Akt, and to a lesser extent,
-Akt, were induced by insulin in wild-type brown adipocytes.
The lack of IRS-1 blunted the phosphorylation of Akt isoforms
in response to insulin; this effect was recovered after reconsti-
tution with IRS-1wt. These results indicate that activation of
Akt isoforms (-, -, and -) in brown adipocytes depends on the
IRS-1-mediated PI 3-kinase-signaling pathway because IRS-2
was unable to compensate this response.
Immortalized wild-type brown adipocytes induced UCP-1 ex-
pression upon insulin stimulation as previously shown in pri-
mary cells (15). However, these cells are unable to respond to
insulin in inducing the transactivation of the UCP-1 gene and,
subsequently, the expression of the protein in the absence of
IRS-1 or when Akt was inhibited by ML-9 compound. These
results support the notion that insulin through the IRS-1/PI
3-kinase/Akt signaling pathway might activate nuclear pro-
teins, as discussed below, which can bind to the UCP-1 pro-
moter, addressing the point of the underlying molecular mech-
anism involved in the insulin effect on UCP-1 gene expression.
However, insulin did not regulate UCP-2 nor UCP-3, strength-
ening the point that only UCP-1, the tissue-specific marker, is
regulated by insulin in an IRS-1-dependent manner.
The C/EBP and PPAR families of transcription factors have
an important role in the induction of fully differentiated brown
adipocyte phenotype. Regarding thermogenesis, C/EBP has
been shown to transactivate the UCP-1 gene (37, 43). In fact,
C/EBP expression increases in rat brown adipose tissue dur-
ing late fetal development concurrently with the expression of
UCP-1 (5). In addition, both C/EBP and UCP-1 mRNAs are
up-regulated by insulin in brown adipocyte primary cultures in
a similar fashion (14). Here we show that in immortalized fetal
brown adipocytes p42C/EBP is up-regulated by insulin in an
IRS-1-dependent manner. Furthermore, insulin induced DNA
FIG. 7. Binding of tyrosines 608, 628, and 658 to p85 is sufficient to restore PI-3 kinase/Akt signaling and insulin-induced UCP-1
and FAS expression in brown adipocytes. A, IRS-1-deficient brown adipocytes (clone 4) were transfected with the pCMVhisIRS-1wt (IRS-1wt)
and pCMVhisIRS-1Tyr-608/Tyr-628/Tyr-658 (IRS-13Y) cDNA constructs. 24 h after transfection, histidinol (10 mM) was added to select stable transfec-
tants, and the expression of IRS-1wt and the mutant IRS-1Tyr-608/Tyr-628/Tyr-658 was assessed by Western blot analysis with the anti-IRS-1 antibody.
B, quiescent cells (IRS-1/ and IRS-1wt and IRS-1Tyr-608/Tyr-628/Tyr-658 stable transfectants) were stimulated with various doses of insulin for 5 min,
and total protein (inositol trisphosphate (PIP)) was either immunoprecipitated (IP) with the anti-IRS-1 antibody followed by an in vitro PI 3-kinase
assay as described above or submitted to Western blot analysis with anti-phospho-Akt (PAkt) and anti-Akt antibodies. A representative experiment
of three is shown. C, cells were serum-starved for 20 h and further cultured for 24 h in the absence or presence of insulin (10–100 nM).
Mitochondrial protein extracts were analyzed by Western blot with anti-UCP-1 or anti-cytochrome c antibodies. D, quiescent cells were cultured
for 24 h in serum-free medium either in the absence or presence of insulin (10–100 nM). At the end of the culture time, total RNA (10 g) was
submitted to Northern blot analysis and hybridized with labeled FAS and 18 S rRNA cDNAs.
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binding activity of the newly synthesized C/EBP protein in a
similar fashion. Consequently, our results demonstrate the
requirement of C/EBP binding sites within the UCP-1 pro-
moter in mediating the insulin effect via IRS-1/PI 3-kinase/Akt,
indicating that this signaling during development may be cru-
cial for the expression and DNA binding activity of transcrip-
tion factors involved in the onset of brown fat differentiation.
Moreover, the UCP-1 enhancer also contains a response ele-
ment for PPAR (44). In addition, its effect is strongly in-
creased by binding of the cold-inducible coactivator PGC-1
(PPAR coactivator-1) through the ligand-dependent way (45,
46). However, PPAR expression in brown adipocytes is not
regulated by insulin (14). Fetal brown adipocytes lacking IRS-1
up-regulated UCP-1 expression and transactivated the UCP-1
promoter in the absence of insulin when C/EBP or PPAR
were overexpressed, reaching levels even higher than those
observed in wild-type cells. Insulin stimulation of C/EBP- or
PPAR-IRS-1/ cells failed to further increase the transcrip-
tional activity of the UCP-1 promoter and UCP-1 expression.
These results indicate that the lack of insulin signaling
through IRS-1/Akt pathway can by bypassed by C/EBP or
PPAR. Importantly, FAS mRNA was also up-regulated in
both C/EBP and PPAR IRS-1/ cell lines. However, the
effect of C/EBP overexpression was more prominent on FAS
expression than that of PPAR, suggesting that the effect of
insulin on adipogenic markers in fetal brown adipocytes is
mainly mediated by the modulation of C/EBP. Moreover, in-
sulin further increased FAS mRNA expression in C/EBP-IRS-
1/ cells but not in PPAR-IRS-1/ cells. These data clearly
indicate that C/EBP, but not PPAR, reconstitutes insulin
sensitivity in brown adipocytes in an IRS-1-independent man-
ner and are entirely consistent with those previously described
by El-Jack et al. (47) regarding the role of C/EBP in inducing
insulin sensitivity in glucose transport during the adipocytic
differentiation of 3T3L1 fibroblasts.
We have recently shown that insulin stimulates mitogenesis
in brown adipocytes by a mechanism that exclusively involves
IRS-1Tyr895 through its binding to Grb-2 and, subsequently,
mitogen-activated protein kinase activation (40). In this study,
we demonstrated that the reconstitution of IRS-1/ cells with
the IRS-1Phe-895 mutant, which lacked Grb-2 binding, failed to
activate mitogen-activated protein kinase and mitogenesis in
response to insulin. The results presented in the present paper
demonstrated that IRS-1-deficient brown adipocytes reconsti-
tuted with IRS-1Phe-895 maintained intact PI 3-kinase/Akt sig-
naling in response to insulin. Consequently, IRS-1Phe-895-recon-
stituted cells maintained insulin sensitivity in inducing
C/EBP and UCP-1 expression and the transactivation of
UCP-1 promoter, regardless the expected lack of mitogen-acti-
vated protein kinase activation. Moreover, FAS expression was
also unaltered in IRS-1Phe-895-reconstituted cells. Despite the
fact that mitogen-activated protein kinase has been proposed
as a negative effector of adipocyte differentiation (48), in this
study we have not found differences in the expression of brown
adipocyte adipogenic and thermogenic differentiation markers
after reconstitution of IRS-1-deficient brown adipocytes with
either IRS-1wt or IRS-1Phe-895. Indeed, Fasshauer et al. (42) do
not find an improvement in the differentiation capacity of IRS-
1/ brown preadipocytes upon inhibition of mitogen-activated
protein kinase. Finally, in the present study we have also
evaluated the essential role of IRS-1/PI 3-kinase/Akt signaling
by reconstituting IRS-1 null brown adipocytes with the IRS-
1Tyr-608/Tyr-628/Tyr-658 mutant, which contains only three tyro-
sine residues in YXXM motifs (608, 628, and 658) among the 18
potential tyrosine phosphorylation sites. This mutant fully re-
stored PI 3-kinase and Akt activation by insulin in fetal brown
adipocytes, leading to a recovery of both UCP-1 and FAS ex-
pression, virtually lost in IRS-1/ cells. These data indicate
that tyrosines 608, 628, and 658 of IRS-1 are necessary and
sufficient for the induction of UCP-1 expression by insulin.
In conclusion, the current findings provide strong evidence
that insulin regulation of UCP-1 expression is mediated by
IRS-1 through the PI 3-kinase/Akt-signaling pathway in brown
adipocytes and that UCP-2 and UCP-3 are not regulated by
insulin. Three tyrosine motifs (608, 628, and 658) in the IRS-1
molecule have been identified as critical in inducing UCP-1
gene expression. Overexpression of either C/EBP, whose ex-
pression is regulated by insulin in IRS-1-dependent manner, or
PPAR bypasses IRS-1 signaling in inducing UCP-1 in the
absence of insulin. However, C/EBP, but not PPAR, recon-
stitutes insulin sensitivity regarding adipogenic markers.
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